tradingkey.logo
tradingkey.logo
Pesquisar

GeneDx Holdings Corp

WGS
Adicionar à lista de desejos
71.710USD
+3.060+4.46%
Fechamento 07/01, 16:00ETCotações atrasadas em 15 min
2.13BValor de mercado
PerdaP/L TTM

Mais detalhes de GeneDx Holdings Corp Empresa

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

Informações de GeneDx Holdings Corp

Código da empresaWGS
Nome da EmpresaGeneDx Holdings Corp
Data de listagemSep 04, 2020
CEOStueland (Katherine A)
Número de funcionários1000
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 04
Endereço333 Ludlow Street
CidadeSTAMFORD
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal06902
Telefone18887291206
Sitehttps://sema4.com/
Código da empresaWGS
Data de listagemSep 04, 2020
CEOStueland (Katherine A)

Executivos da empresa GeneDx Holdings Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
185.99K
-20.43%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
39.95K
+12.54%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
26.33K
-25.95%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
185.99K
-20.43%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
39.95K
+12.54%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
26.33K
-25.95%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
20.13K
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de GeneDx Holdings Corp?

Os cinco principais acionistas de GeneDx Holdings Corp são: Mr. Joshua Ruch

Qual é a maior fonte de receita da GeneDx Holdings Corp?

Em 2026Q4, o segmento de negócios Patients with third party insurance gerou a maior receita para GeneDx Holdings Corp, totalizando 345.24M e representando 80.75% da receita total.